Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Pfisterer

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Journal of the American College of Cardiology|May 3, 2005
Right atrial pacing impairs cardiac function during resynchronization therapy: acute effects of DDD pacing compared to VDD pacingAlain Bernheim, Peter Ammann, Christian Sticherling, et al.
International Journal of Cardiology|December 20, 2015
Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter studyJosep Lupón, Sandra Sanders-van Wijk, James L Januzzi, et al.
Journal of the American College of Cardiology|October 18, 2003
Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trialTimothy A Sanborn, Lynn A Sleeper, John G Webb, et al.
The New England Journal of Medicine|November 18, 2010
Drug-eluting versus bare-metal stents in large coronary arteriesChristoph Kaiser, Soeren Galatius, Paul Erne, et al.
The American Journal of Medicine|May 4, 2019
Prognostic Significance of Longitudinal Clinical Congestion Pattern in Chronic Heart Failure: Insights From TIME-CHF TrialJustas Simonavičius, Sandra Sanders van-Wijk, Peter Rickenbacher, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 20, 2017
Second generation drug-eluting stents versus bare-metal stents for percutaneous coronary intervention of the proximal left anterior descending artery: An analysis of the BASKET-PROVE I and II trialsFernanda Marinho Mangione, Tor Biering-Sørensen, Kotaro Nochioka, et al.
American Heart Journal|July 24, 2007
Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trialsCheuk-Kit Wong, L Kristin Newby, Manju V Bhapker, et al.
American Heart Journal|March 29, 2008
Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and designMatthias Pfisterer, Osmund Bertel, Piero O Bonetti, et al.
Journal of the American Heart Association|October 9, 2020
Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled TrialGregor Fahrni, Ahmed Farah, Thomas Engstrøm, et al.
International Journal of Cardiology|July 16, 2013
Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes--results from the BASKET PROVE trialMagnus Thorsten Jensen, Christoph Kaiser, Karl Erik Sandsten, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Journal of the American College of Cardiology|May 3, 2005
Right atrial pacing impairs cardiac function during resynchronization therapy: acute effects of DDD pacing compared to VDD pacingAlain Bernheim, Peter Ammann, Christian Sticherling, et al.
International Journal of Cardiology|December 20, 2015
Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter studyJosep Lupón, Sandra Sanders-van Wijk, James L Januzzi, et al.
Journal of the American College of Cardiology|October 18, 2003
Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trialTimothy A Sanborn, Lynn A Sleeper, John G Webb, et al.
The New England Journal of Medicine|November 18, 2010
Drug-eluting versus bare-metal stents in large coronary arteriesChristoph Kaiser, Soeren Galatius, Paul Erne, et al.
The American Journal of Medicine|May 4, 2019
Prognostic Significance of Longitudinal Clinical Congestion Pattern in Chronic Heart Failure: Insights From TIME-CHF TrialJustas Simonavičius, Sandra Sanders van-Wijk, Peter Rickenbacher, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 20, 2017
Second generation drug-eluting stents versus bare-metal stents for percutaneous coronary intervention of the proximal left anterior descending artery: An analysis of the BASKET-PROVE I and II trialsFernanda Marinho Mangione, Tor Biering-Sørensen, Kotaro Nochioka, et al.
American Heart Journal|July 24, 2007
Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trialsCheuk-Kit Wong, L Kristin Newby, Manju V Bhapker, et al.
American Heart Journal|March 29, 2008
Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and designMatthias Pfisterer, Osmund Bertel, Piero O Bonetti, et al.
Journal of the American Heart Association|October 9, 2020
Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled TrialGregor Fahrni, Ahmed Farah, Thomas Engstrøm, et al.
International Journal of Cardiology|July 16, 2013
Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes--results from the BASKET PROVE trialMagnus Thorsten Jensen, Christoph Kaiser, Karl Erik Sandsten, et al.
Pageof 8